BIOLIPOX
Biolipox is a research-intense pharmaceutical company that develops treatments for inflammatory diseases. This includes widespread diseases such as asthma, COPD, rhinitis, and inflammatory and rheumatic pain. The company offers its users with current arachidonic acid research. Arachidonic acid is an endogenous substance that plays a central role in the development of inflammatory diseases. It is an established research area that empowers several drugs such as Aspirin, Naproxen, and Singulair. Biolipox is a Sweden-based company that was founded in 2000 and the company was acquired by Orexo on November 23, 2007.
BIOLIPOX
Industry:
Biopharma Biotechnology Health Care Medical Pharmaceutical
Founded:
2000-01-01
Address:
Solna, Stockholms Lan, Sweden
Country:
Sweden
Status:
Active
Total Funding:
62 M USD
Similar Organizations
AM Pharma
AM-Pharma is a biopharmaceutical company focused on the development of therapeutics to treat inflammatory and infectious diseases.
BIOVIIIx
BIOVIIIx is a biotechnology and pharmaceutical company that develops medicine in the field of rare diseases.
Corticrine
Corticrine operates as a pharmaceutical company that develops new therapies for Alzheimer’s dementia.
Ducentis BioTherapeutics
Ducentis is a pre-clinical stage company that aims to develop novel therapies for inflammation and autoimmune disease.
IntelliHep
IntelliHep is a spin-out company developing novel drugs for Alzheimers disease and cancer.
Ixaltis
Ixaltis is a pharmaceutical company that develops therapeutics to treat genitourinary disorders with unsatisfied medical needs.
Spinal Cord Therapeutics GmbH
Spinal Cord Therapeutics GmbH develops treatments for spinal cord injury.
Systasy Bioscience
Systasy Bioscience is a biomedical research has radically changed the view to new treatment strategies.
Triptcor Pharmaceuticals
Triptcor Pharmaceuticals, a start-up based on inflammatory disease.
VitaLeech Bioscience
VitaLeech Bioscience develops a recombinant enzyme for the treatment of periodontitis, a form of inflammation of the gum.
Investors List
Crédit Lyonnais Private Equity
Crédit Lyonnais Private Equity investment in Series C - Biolipox
Sofinnova Partners
Sofinnova Partners investment in Series C - Biolipox
Auriga Partners
Auriga Partners investment in Series C - Biolipox
HealthCap
HealthCap investment in Series C - Biolipox
Apax Partners
Apax Partners investment in Series C - Biolipox
Angel Investment Network
Angel Investment Network investment in Series C - Biolipox
Auriga Partners
Auriga Partners investment in Series B - Biolipox
Crédit Lyonnais Private Equity
Crédit Lyonnais Private Equity investment in Series B - Biolipox
Sofinnova Partners
Sofinnova Partners investment in Series B - Biolipox
Apax Partners
Apax Partners investment in Series B - Biolipox
More informations about "Biolipox"
Biolipox - Crunchbase Company Profile & Funding
Biolipox is a research-intense pharmaceutical company that develops treatments for inflammatory diseases. This includes widespread diseases such as asthma, COPD, rhinitis, and …See details»
Biolipox Company Profile 2024: Valuation, Investors, Acquisition ...
Provider of drugs for inflammatory diseases. The company is focused on therapies for inflammatory diseases including pain management and respiratory diseases like asthma and …See details»
Orexo to acquire Biolipox - building a specialty pharma
Oct 15, 2007 · Orexo to acquire Biolipox - building a specialty pharma company driven by innovation Orexo AB (OMX Nordic List, Mid Cap: ORX) and the principal owners of Biolipox …See details»
Sweden’s Orexo and Biolipox complete $137 million merger
Nov 26, 2007 · Orexo has completed its acquisition of fellow Swedish firm Biolipox, a deal which the firms say will create “an innovative specialty pharma company”.See details»
Biolipox - Funding, Financials, Valuation & Investors - Crunchbase
Biolipox is a research-intense pharmaceutical company that develops new treatments for inflammatory diseasesSee details»
Orexo To Acquire Biolipox - PHARMACEUTICAL ONLINE
Orexo AB and the principal owners of Biolipox AB have reached an agreement under which Orexo will acquire Biolipox, an innovative Swedish research-based pharmaceutical company that …See details»
Orexo Acquires Biolipox - Business Wire
Nov 12, 2007 · Biolipox is a Swedish research-intense pharmaceutical company that focuses on developing novel, effective drugs for treating respiratory diseases and other inflammatory …See details»
Orexo AB to Acquire Biolipox AB - Building a Specialty ... - BioSpace
Oct 15, 2007 · STOCKHOLM, Sweden--(BUSINESS WIRE)--Regulatory News: Orexo AB (STO:ORX) and the principal owners of Biolipox AB have reached an agreement under which …See details»
Biolipox AB - Drug pipelines, Patents, Clinical trials - Synapse
Explore Biolipox AB with its drug pipeline, therapeutic area, technology platform, 2 clinical trials, and 6 literature, Drug:Liposomal Cetirizine.See details»
Biolipox - Crunchbase
Biolipox is a research-intense pharmaceutical company that develops new treatments for inflammatory diseasesSee details»
Orexo buys Biolipox for pain pipeline - outsourcing-pharma.com
Oct 15, 2007 · Orexo will splash out to the tune of SEK856m (€94m) on fellow Swedish pharma company Biolipox, thus adding four new projects to its pipeline and creating a firm that …See details»
Biolipox AB - Company Profile and News - Bloomberg Markets
Biolipox AB researches and develops treatments for respiratory and inflammatory diseases. The Company provides arachidonic acid research and drugs for the treatment of asthma, chronic …See details»
Biolipox AB - insights.citeline.com
Founded in June 2000 by two professors from Sweden's Karolinska Institute, Biolipox AB is focusing on the role of arachidonic acid in inflammation, and looking to develop an improved …See details»
Boehringer Ingelheim and Biolipox sign agreement on a new class …
Boehringer Ingelheim GmbH and Biolipox announced today that they agreed to a worldwide exclusive research and license collaboration. The aim of the collaboration is to develop a new …See details»
Orexo acquires Biolipox - 2007-11-23 - Crunchbase
Nov 23, 2007 · Acquiring Organization: Orexo Orexo is a pharmaceutical company developing improved treatments using proprietary drug delivery technology. Announced Date Nov 23, 2007See details»
Orexo to acquire Biolipox - building a specialty pharma company …
Orexo AB (OMX Nordic List, Mid Cap: ORX) and the principal owners of Biolipox AB have reached an agreement under which Orexo will acquire Biolipox, an innovative Swedish …See details»
Torbjørn Bjerke - BIO International Convention | BIO
Previously, he was president and CEO of Biolipox AB, Executive Vice President, R&D, ALK Pharmaceuticals, and director of pharmacology at AstraZeneca. Dr Bjerke holds a PhD in …See details»
Biolipox Raises EUR21M To Fund Drug Discovery, Development
Jan 22, 2003 · Biolipox was established in June 2000 by scientific founders Hans-Erik Claesson and Magnus Björkholm, both of the Karolinska Institute in Stockholm. Its primary focus is on …See details»
Biolipox Ab - Products, Competitors, Financials, Employees ...
Orexo is a pharmaceutical company, focusing on development of new, patented drugs by combining well-documented substances with innovative technologies, and the development of …See details»
Research programme: 15-lipoxygenase inhibitors - Orexo/Johnson ...
Feb 1, 2012 · Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.See details»